LLY · News · 20260826N
Products and Technology - Alzheimer’s Blood Test
ELI LILLY & Co · 2026-08-26 · Importance 38 · Surprise 60 · In source text
The FDA approved a blood test developed by Eli Lilly and Roche to help identify Alzheimer’s disease. The approval strengthens Lilly’s position in Alzheimer’s diagnostics alongside its Kisunla franchise. The report provides no specific dollar impact or implementation timeframe.
Key facts
- The FDA approved a new blood test developed with Roche that Eli Lilly has been involved with to help identify (Alzheimer's-related indication as reported). source
- Eli Lilly has an Alzheimer's drug named Kisunla. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | The FDA approved a new blood test developed with Roche that Eli Lilly has been involved with to help identify (Alzheimer's-related… |